Does PEXIDARTINIB Cause Disease progression? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Disease progression have been filed in association with PEXIDARTINIB (Turalio). This represents 3.7% of all adverse event reports for PEXIDARTINIB.
36
Reports of Disease progression with PEXIDARTINIB
3.7%
of all PEXIDARTINIB reports
3
Deaths
11
Hospitalizations
How Dangerous Is Disease progression From PEXIDARTINIB?
Of the 36 reports, 3 (8.3%) resulted in death, 11 (30.6%) required hospitalization.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for PEXIDARTINIB.
What Other Side Effects Does PEXIDARTINIB Cause?
Fatigue (378)
Product dose omission issue (335)
Hair colour changes (327)
Nausea (213)
Pruritus (186)
Aspartate aminotransferase increased (134)
Rash (131)
Off label use (130)
Alanine aminotransferase increased (124)
Diarrhoea (106)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which PEXIDARTINIB Alternatives Have Lower Disease progression Risk?
PEXIDARTINIB vs PHENACETIN
PEXIDARTINIB vs PHENAZOPYRIDINE
PEXIDARTINIB vs PHENCYCLIDINE
PEXIDARTINIB vs PHENELZINE
PEXIDARTINIB vs PHENOBARBITAL